Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities

Katherine M Krajewski1, Marta Braschi-Amirfarzan1, Pamela J DiPiro1

  • 1Department of Imaging, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA.

Insights

Personalized cancer treatments, including targeted therapies, are revolutionizing oncology. This review covers anti-angiogenic and molecular targeted therapies, focusing on response patterns and imaging of drug toxicities.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiology

Background:

  • Oncology is rapidly evolving towards personalized cancer treatment.
  • Targeted therapies focusing on molecular features and the tumor microenvironment are increasingly common.
  • Understanding treatment response and toxicity is crucial for effective patient management.

Purpose of the Study:

  • To review anti-angiogenic and molecular targeted therapies in oncology.
  • To focus on typical and atypical response patterns to these therapies.
  • To discuss imaging manifestations of drug-induced toxicities.

Main Methods:

  • Literature review of anti-angiogenic and molecular targeted therapies.
  • Analysis of response patterns in cancer patients.
  • Review of imaging findings related to drug toxicities.

Main Results:

  • Discussion of various molecular targeted agents and their mechanisms.
  • Identification of characteristic and unusual treatment response patterns.
  • Correlation of specific imaging findings with known drug toxicities.

Conclusions:

  • Molecular targeted therapies represent a significant advancement in cancer care.
  • Accurate interpretation of imaging is essential for assessing treatment efficacy and managing adverse events.
  • Further research is needed to optimize the use of targeted therapies and their monitoring.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K